MoneyWorks4Me

The revenue for the September 2021 quarter is pegged at Rs. 594.89 millions, about 5.56% up against Rs. 563.53 millions recorded during the year-ago period.Profit for the quarter ended September 2021 rises by 82.38% to Rs. 73.08  millions from Rs. 40.07 millions.Operating profit surged to 105.66 millions from the corresponding previous quarter of 52.47 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 594.89 563.53 5.56 1194.88 880.05 35.77 1879.46 1585.68 18.53
Other Income 2.85 4.14 -31.16 11.07 11.98 -7.60 43.93 25.26 73.91
PBIDT 105.66 52.47 101.37 206.62 86.77 138.12 234.72 110.59 112.24
Interest 0.63 1.17 -46.15 1.68 2.48 -32.26 5.14 5.14 0.00
PBDT 105.03 51.30 104.74 204.94 84.29 143.14 229.58 105.45 117.71
Depreciation 2.28 2.75 -17.09 5.11 5.50 -7.09 10.86 11.30 -3.89
PBT 102.75 48.55 111.64 199.83 78.79 153.62 218.72 94.15 132.31
TAX 29.67 8.48 249.88 58.26 13.53 330.60 48.14 15.44 211.79
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 73.08 40.07 82.38 141.57 65.26 116.93 170.58 78.71 116.72
Equity 130.99 130.99 0.00 130.99 130.99 0.00 130.99 130.99 0.00
PBIDTM(%) 17.76 9.31 90.76 17.29 9.86 75.38 12.49 6.97 79.07
Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..